BH

Bipinkumar Hridaynarayan Pandey

Active Director Director DIN 07594238
DIN 07594238 First appointment Jan 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Bipinkumar Hridaynarayan Pandey

Data last updated:

Bipinkumar Hridaynarayan Pandey is a Director at Ophelia Pharmaceutical Private Limited (since 2017). The company operates in Pharma.

DIN 07594238
Primary Designation Director
Industry Pharma
First Appointment 03 Jan 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jan 20172017Active

Board colleagues of Bipinkumar Hridaynarayan Pandey

Directorship timeline

Open interactive timeline →
Ophelia Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Bipinkumar Hridaynarayan Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bipinkumar Hridaynarayan Pandey

Bipinkumar Hridaynarayan Pandey currently holds 1 directorship: Ophelia Pharmaceutical Private Limited (Director, since 03 Jan 2017).

Bipinkumar Hridaynarayan Pandey was first appointed on 03 Jan 2017 as Director at Ophelia Pharmaceutical Private Limited.

The current boards of Bipinkumar Hridaynarayan Pandey's companies include Abhijeet Rajendra Chaube (Ophelia Pharmaceutical Private Limited), Manish Bhuleshwarnath Shukla (Ophelia Pharmaceutical Private Limited), Virendra Ramlal Pal (Ophelia Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available